These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 34729610)

  • 21. Sentinel Lymph Node Mapping With Near-Infrared Fluorescent Imaging Using Indocyanine Green: A New Tool for Laparoscopic Platform in Patients With Endometrial and Cervical Cancer.
    Buda A; Bussi B; Di Martino G; Di Lorenzo P; Palazzi S; Grassi T; Milani R
    J Minim Invasive Gynecol; 2016 Feb; 23(2):265-9. PubMed ID: 26455525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Laparoscopic sentinel node mapping with intracervical indocyanine green injection for endometrial cancer: the SENTIFAIL study - a multicentric analysis of predictors of failed mapping.
    Sozzi G; Fanfani F; Berretta R; Capozzi VA; Uccella S; Buono N; Giallombardo V; Di Donna MC; Monterossi G; Restaino S; Capasso I; Dinoi G; Scambia G; Chiantera V
    Int J Gynecol Cancer; 2020 Nov; 30(11):1713-1718. PubMed ID: 32868384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact on survival of two different staging strategies in apparent early stage endometrial cancer comparing sentinel lymph nodes mapping algorithm and selective lymphadenectomy: An Italian retrospective analysis of two reference centers.
    Buda A; Di Martino G; Restaino S; De Ponti E; Monterossi G; Giuliani D; Ercoli A; Dell'Orto F; Dinoi G; Grassi T; Scambia G; Fanfani F
    Gynecol Oncol; 2017 Dec; 147(3):528-534. PubMed ID: 29032824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of sentinel lymph nodes in patients with endometrial cancer undergoing robotic-assisted staging: a comparison of colorimetric and fluorescence imaging.
    Holloway RW; Bravo RA; Rakowski JA; James JA; Jeppson CN; Ingersoll SB; Ahmad S
    Gynecol Oncol; 2012 Jul; 126(1):25-9. PubMed ID: 22507531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective study of sentinel lymph node mapping for endometrial cancer.
    Togami S; Kawamura T; Fukuda M; Yanazume S; Kamio M; Kobayashi H
    Int J Gynaecol Obstet; 2018 Dec; 143(3):313-318. PubMed ID: 30125949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical analysis of 76 cases of sentinel lymph node detection in cervical cancer and endometrial cancer].
    Liang SC; Wang ZQ; Wang JL
    Zhonghua Fu Chan Ke Za Zhi; 2017 Sep; 52(9):605-611. PubMed ID: 28954449
    [No Abstract]   [Full Text] [Related]  

  • 27. Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO).
    Ballester M; Dubernard G; Lécuru F; Heitz D; Mathevet P; Marret H; Querleu D; Golfier F; Leblanc E; Rouzier R; Daraï E
    Lancet Oncol; 2011 May; 12(5):469-76. PubMed ID: 21489874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Robot-assisted Sentinel Lymph Node Mapping and Inguinal Lymph Node Dissection Using Near-infrared Fluorescence in Vulvar Cancer.
    Mohammad A; Hunter MI
    J Minim Invasive Gynecol; 2019; 26(5):968-972. PubMed ID: 30959199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The safety and feasibility of minimally invasive sentinel lymph node staging using indocyanine green in the management of endometrial cancer.
    Mendivil AA; Abaid LN; Brown JV; Mori KM; Beck TL; Epstein HD; Micha JP; Goldstein BH
    Eur J Obstet Gynecol Reprod Biol; 2018 May; 224():29-32. PubMed ID: 29529474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparing indocyanine green, technetium, and blue dye for sentinel lymph node mapping in endometrial cancer.
    How J; Gotlieb WH; Press JZ; Abitbol J; Pelmus M; Ferenczy A; Probst S; Gotlieb R; Brin S; Lau S
    Gynecol Oncol; 2015 Jun; 137(3):436-42. PubMed ID: 25870917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A retrospective validation study of sentinel lymph node mapping for high-risk endometrial cancer.
    Wang T; Hu Y; He Y; Sun P; Guo Z
    Arch Gynecol Obstet; 2019 May; 299(5):1429-1435. PubMed ID: 30747328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparing Single-Site and Multiport Robotic Hysterectomy with Sentinel Lymph Node Mapping for Endometrial Cancer: Surgical Outcomes and Cost Analysis.
    Moukarzel LA; Sinno AK; Fader AN; Tanner EJ
    J Minim Invasive Gynecol; 2017; 24(6):977-983. PubMed ID: 28599884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sentinel lymph nodes (SLN) in endometrial cancer: The relationship between primary tumor histology, SLN metastasis size, and non-sentinel node metastasis.
    Kennard JA; Stephens AJ; Ahmad S; Zhu X; Singh C; McKenzie ND; Kendrick JE; Holloway RW
    Gynecol Oncol; 2019 Jul; 154(1):53-59. PubMed ID: 31027899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Laparoscopic Sentinel Node Mapping in Endometrial Cancer After Hysteroscopic Injection of Indocyanine Green.
    Martinelli F; Ditto A; Bogani G; Signorelli M; Chiappa V; Lorusso D; Haeusler E; Raspagliesi F
    J Minim Invasive Gynecol; 2017 Jan; 24(1):89-93. PubMed ID: 27725278
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Accuracy of robotic sentinel lymph node detection (RSLND) for patients with endometrial cancer (EC).
    Desai PH; Hughes P; Tobias DH; Tchabo N; Heller PB; Dise C; Slomovitz BM
    Gynecol Oncol; 2014 Nov; 135(2):196-200. PubMed ID: 25175452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Value and best way for detection of Sentinel lymph node in early stage endometrial cancer: Selective lymphadenectomy algorithm.
    El-Agwany AS; Meleis MH
    Eur J Obstet Gynecol Reprod Biol; 2018 Jun; 225():35-39. PubMed ID: 29660577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tracer injection sites and combinations for sentinel lymph node detection in patients with endometrial cancer.
    Niikura H; Kaiho-Sakuma M; Tokunaga H; Toyoshima M; Utsunomiya H; Nagase S; Takano T; Watanabe M; Ito K; Yaegashi N
    Gynecol Oncol; 2013 Nov; 131(2):299-303. PubMed ID: 23988415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A prospective evaluation of the sentinel node mapping algorithm in endometrial cancer and correlation of its performance against endometrial cancer risk subtypes.
    Rajanbabu A; Agarwal R
    Eur J Obstet Gynecol Reprod Biol; 2018 May; 224():77-80. PubMed ID: 29554604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The efficacy of sentinel lymph node mapping with indocyanine green in cervical cancer.
    Kim JH; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    World J Surg Oncol; 2018 Mar; 16(1):52. PubMed ID: 29523141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors for failure of sentinel lymph node mapping using indocyanine green/near-infrared fluorescent imaging in endometrial cancer.
    Taşkın S; Sarı ME; Altın D; Ersöz CC; Gökçe A; Yüksel S; Kankaya D; Ortaç F
    Arch Gynecol Obstet; 2019 Jun; 299(6):1667-1672. PubMed ID: 30927059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.